These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 9450775)
1. Compound heterozygous genotype is associated with protracted juvenile neuronal ceroid lipofuscinosis. Wisniewski KE; Zhong N; Kaczmarski W; Kaczmarski A; Kida E; Brown WT; Schwarz KO; Lazzarini AM; Rubin AJ; Stenroos ES; Johnson WG; Wisniewski TM Ann Neurol; 1998 Jan; 43(1):106-10. PubMed ID: 9450775 [TBL] [Abstract][Full Text] [Related]
2. Protracted course of juvenile ceroid lipofuscinosis associated with a novel CLN3 mutation (p.Y199X). Sarpong A; Schottmann G; Rüther K; Stoltenburg G; Kohlschütter A; Hübner C; Schuelke M Clin Genet; 2009 Jul; 76(1):38-45. PubMed ID: 19489875 [TBL] [Abstract][Full Text] [Related]
3. Novel CLN3 mutation predicted to cause complete loss of protein function does not modify the classical JNCL phenotype. Kwon JM; Rothberg PG; Leman AR; Weimer JM; Mink JW; Pearce DA Neurosci Lett; 2005 Oct; 387(2):111-4. PubMed ID: 16087292 [TBL] [Abstract][Full Text] [Related]
4. Profound infantile neuroretinal dysfunction in a heterozygote for the CLN3 genetic defect. de los Reyes E; Dyken PR; Phillips P; Brodsky M; Bates S; Glasier C; Mrak RE J Child Neurol; 2004 Jan; 19(1):42-6. PubMed ID: 15032383 [TBL] [Abstract][Full Text] [Related]
5. Genotype-phenotype correlations in neuronal ceroid lipofuscinosis due to palmitoyl-protein thioesterase deficiency. Hofmann SL; Das AK; Yi W; Lu JY; Wisniewski KE Mol Genet Metab; 1999 Apr; 66(4):234-9. PubMed ID: 10191107 [TBL] [Abstract][Full Text] [Related]
6. A 30-year follow-up of a neuronal ceroid lipofuscinosis patient with mutations in CLN3 and protracted disease course. Aberg L; Lauronen L; Hämäläinen J; Mole SE; Autti T Pediatr Neurol; 2009 Feb; 40(2):134-7. PubMed ID: 19135632 [TBL] [Abstract][Full Text] [Related]
7. Late onset juvenile neuronal ceroid-lipofuscinosis with granular osmiophilic deposits (GROD). Hofman IL; Taschner PE Am J Med Genet; 1995 Jun; 57(2):165-7. PubMed ID: 7668323 [TBL] [Abstract][Full Text] [Related]
8. Late infantile neuronal ceroid lipofuscinosis: a new mutation in Arabs. Goldberg-Stern H; Halevi A; Marom D; Straussberg R; Mimouni-Bloch A Pediatr Neurol; 2009 Oct; 41(4):297-300. PubMed ID: 19748052 [TBL] [Abstract][Full Text] [Related]
10. Application of chromosome 16 markers in the differential diagnosis of neuronal ceroid-lipofuscinosis. Taschner PE; de Vos N; Catsman-Berrevoets CE; van Duinen SG; Lindhout D; Breuning MH Am J Med Genet; 1995 Jun; 57(2):338-43. PubMed ID: 7668359 [TBL] [Abstract][Full Text] [Related]
11. A novel mutation af Cln3 associated with delayed-classic juvenile ceroid lipofuscinois and autophagic vacuolar myopathy. Licchetta L; Bisulli F; Fietz M; Valentino ML; Morbin M; Mostacci B; Oliver KL; Berkovic SF; Tinuper P Eur J Med Genet; 2015 Oct; 58(10):540-4. PubMed ID: 26360874 [TBL] [Abstract][Full Text] [Related]
12. A CLN5 mutation causing an atypical neuronal ceroid lipofuscinosis of juvenile onset. Pineda-Trujillo N; Cornejo W; Carrizosa J; Wheeler RB; Múnera S; Valencia A; Agudelo-Arango J; Cogollo A; Anderson G; Bedoya G; Mole SE; Ruíz-Linares A Neurology; 2005 Feb; 64(4):740-2. PubMed ID: 15728307 [TBL] [Abstract][Full Text] [Related]
13. A novel c.1135_1138delCTGT mutation in CLN3 leads to juvenile neuronal ceroid lipofuscinosis. Drack AV; Miller JN; Pearce DA J Child Neurol; 2013 Sep; 28(9):1112-6. PubMed ID: 23877479 [TBL] [Abstract][Full Text] [Related]
14. Clinical and magnetic resonance imaging findings in Batten disease: analysis of the major mutation (1.02-kb deletion). Järvelä I; Autti T; Lamminranta S; Aberg L; Raininko R; Santavuori P Ann Neurol; 1997 Nov; 42(5):799-802. PubMed ID: 9392580 [TBL] [Abstract][Full Text] [Related]
15. Atypical late infantile and juvenile forms of neuronal ceroid lipofuscinosis and their diagnostic difficulties. Wiśniewski KE; Zhong N; Kida E; Kaczmarski W; Kaczmarski A; Connell F; Brooks SS; Brown WT Folia Neuropathol; 1997; 35(2):73-9. PubMed ID: 9377079 [TBL] [Abstract][Full Text] [Related]
16. A novel in-frame mutation in Sher M; Farooq M; Abdullah U; Ali Z; Faryal S; Zakaria M; Ullah F; Bukhari H; Møller RS; Tommerup N; Baig SM Int J Neurosci; 2019 Sep; 129(9):890-895. PubMed ID: 30892110 [No Abstract] [Full Text] [Related]
17. Reevaluation of neuronal ceroid lipofuscinoses: atypical juvenile onset may be the result of CLN2 mutations. Wisniewski KE; Kaczmarski A; Kida E; Connell F; Kaczmarski W; Michalewski MP; Moroziewicz DN; Zhong N Mol Genet Metab; 1999 Apr; 66(4):248-52. PubMed ID: 10191110 [TBL] [Abstract][Full Text] [Related]
18. Refined localization of the Batten disease gene (CLN3) by haplotype and linkage disequilibrium mapping to D16S288-D16S383 and exclusion from this region of a variant form of Batten disease with granular osmiophilic deposits. Mitchison HM; O'Rawe AM; Lerner TJ; Taschner PE; Schlumpf K; D'Arigo K; de Vos N; Gormally E; Phillips HA; Thompson AD Am J Med Genet; 1995 Jun; 57(2):312-5. PubMed ID: 7668353 [TBL] [Abstract][Full Text] [Related]
19. Microglia in juvenile neuronal ceroid lipofuscinosis are primed toward a pro-inflammatory phenotype. Xiong J; Kielian T J Neurochem; 2013 Oct; 127(2):245-58. PubMed ID: 23919525 [TBL] [Abstract][Full Text] [Related]
20. Retinal pathology and function in a Cln3 knockout mouse model of juvenile Neuronal Ceroid Lipofuscinosis (batten disease). Seigel GM; Lotery A; Kummer A; Bernard DJ; Greene ND; Turmaine M; Derksen T; Nussbaum RL; Davidson B; Wagner J; Mitchison HM Mol Cell Neurosci; 2002 Apr; 19(4):515-27. PubMed ID: 11988019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]